DK671187A - Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner ved behandling af neurodegenerative sygdomme - Google Patents
Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner ved behandling af neurodegenerative sygdommeInfo
- Publication number
- DK671187A DK671187A DK671187A DK671187A DK671187A DK 671187 A DK671187 A DK 671187A DK 671187 A DK671187 A DK 671187A DK 671187 A DK671187 A DK 671187A DK 671187 A DK671187 A DK 671187A
- Authority
- DK
- Denmark
- Prior art keywords
- triazol
- aryl
- treatment
- oner
- neurodegenerative diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94463486A | 1986-12-19 | 1986-12-19 | |
US94463486 | 1986-12-19 | ||
US10700187A | 1987-10-16 | 1987-10-16 | |
US10700187 | 1987-10-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK671187D0 DK671187D0 (da) | 1987-12-18 |
DK671187A true DK671187A (da) | 1988-06-20 |
DK172668B1 DK172668B1 (da) | 1999-05-10 |
Family
ID=26804275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198706711A DK172668B1 (da) | 1986-12-19 | 1987-12-18 | 5-Aryl-3H-1,2,4-triazol-3-oner, deres anvendelse til fremstilling af lægemidler til behandling af neurodegenerative sygdomm |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0273309B1 (da) |
JP (1) | JP2593084B2 (da) |
KR (1) | KR880007495A (da) |
AT (1) | ATE116851T1 (da) |
DE (1) | DE3750979T2 (da) |
DK (1) | DK172668B1 (da) |
ES (1) | ES2069528T3 (da) |
GR (1) | GR3015685T3 (da) |
IE (1) | IE65857B1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4966909A (en) * | 1989-12-20 | 1990-10-30 | Merrell Dow Pharmaceuticals | 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants |
AU644500B2 (en) * | 1990-12-20 | 1993-12-09 | Merrell Dow Pharmaceuticals Inc. | 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma |
US5840746A (en) * | 1993-06-24 | 1998-11-24 | Merck Frosst Canada, Inc. | Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
DE19816882A1 (de) * | 1998-04-17 | 1999-10-21 | Boehringer Ingelheim Pharma | Triazolone mit neuroprotektiver Wirkung |
TW200505441A (en) | 2003-03-24 | 2005-02-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitorsⅠ |
RU2394028C2 (ru) | 2004-07-27 | 2010-07-10 | Ф.Хоффманн-Ля Рош Аг | Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы |
US8293778B2 (en) | 2004-07-27 | 2012-10-23 | Roche Palo Alto Llc | Heterocyclic antiviral compounds |
JP2010522706A (ja) | 2007-03-29 | 2010-07-08 | エフ.ホフマン−ラ ロシュ アーゲー | 非ヌクレオシド逆転写酵素阻害剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1126882B (de) * | 1960-05-03 | 1962-04-05 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von 1,2,4-Triazolonen-(5) |
BE621842A (da) * | 1962-08-27 | |||
DE1545646B1 (de) * | 1965-12-15 | 1969-09-18 | Boehringer Sohn Ingelheim | 1,3-Dimethyl-4-(2',4'-dichlorphenyl)-1,2,4-triazolon-(5) und Verfahren zu dessen Herstellung |
DD153953A3 (de) * | 1980-04-01 | 1982-02-17 | Gottfried Schuster | Mittel zur chemotherapie von virosen der kulturpflanzen |
DD160447A1 (de) * | 1981-03-26 | 1983-08-03 | Johannes Dost | Herbizide mittel, die 1,2,4-triazolinone-(5) enthalten |
AR243171A1 (es) * | 1985-10-29 | 1993-07-30 | Merrell Pharma Inc | Procedimiento para preparar 5-aril-2,4-dialquil-3h-1,2,4-triazol-3-tionas. |
-
1987
- 1987-12-15 JP JP62315427A patent/JP2593084B2/ja not_active Expired - Lifetime
- 1987-12-17 ES ES87118727T patent/ES2069528T3/es not_active Expired - Lifetime
- 1987-12-17 DE DE3750979T patent/DE3750979T2/de not_active Expired - Fee Related
- 1987-12-17 AT AT87118727T patent/ATE116851T1/de not_active IP Right Cessation
- 1987-12-17 EP EP87118727A patent/EP0273309B1/en not_active Expired - Lifetime
- 1987-12-18 DK DK198706711A patent/DK172668B1/da not_active IP Right Cessation
- 1987-12-18 IE IE345987A patent/IE65857B1/en not_active IP Right Cessation
- 1987-12-19 KR KR870014559A patent/KR880007495A/ko not_active Application Discontinuation
-
1995
- 1995-04-04 GR GR950400832T patent/GR3015685T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR880007495A (ko) | 1988-08-27 |
IE873459L (en) | 1989-04-16 |
EP0273309A3 (en) | 1991-01-09 |
JP2593084B2 (ja) | 1997-03-19 |
DK172668B1 (da) | 1999-05-10 |
ATE116851T1 (de) | 1995-01-15 |
DK671187D0 (da) | 1987-12-18 |
ES2069528T3 (es) | 1995-05-16 |
EP0273309A2 (en) | 1988-07-06 |
GR3015685T3 (en) | 1995-07-31 |
DE3750979D1 (de) | 1995-02-23 |
EP0273309B1 (en) | 1995-01-11 |
DE3750979T2 (de) | 1995-05-24 |
JPS63170312A (ja) | 1988-07-14 |
IE65857B1 (en) | 1995-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE133564T1 (de) | Flupirtin in kombination mit antiparkinsonika zur bekämpfung von muskelverspannungen | |
EP0335901A4 (en) | Methods and compositions for the treatment of non-ige-mediated diseases | |
DK0414275T3 (da) | Fremgangsmåde til fremtilling af cycliske aminosyrederivater samt mellemprodukter | |
MX9101869A (es) | Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas | |
DK0446570T3 (da) | Gabapentin og dets derivater til behandling af neurodegenerative sygdomme | |
ATE194593T1 (de) | 3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten | |
DE3769867D1 (de) | Vorrichtung zur gegenseitigen ausrichtung von verschiedenfarbigen strahlbuendeln und visiereinrichtung, die diese vorrichtung enthaelt. | |
DK671187D0 (da) | Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner ved behandling af neurodegenerative sygdomme | |
DE68925004T2 (de) | Verwendung von 2,3,4,5-Tetrahydro-1H-3-Benzazepinen bei der Behandlung von neurologischen Störungen. | |
DK0435177T3 (da) | 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler | |
DK671087A (da) | Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva | |
GR3007508T3 (da) | ||
DK532087D0 (da) | Farmaceutiske praeparater til behandling af hjernelidelser paa funktional og organisk basis | |
DE59104649D1 (de) | Verfahren zur Herstellung von N,N,N',N'-Tetraglycidyl-3,3'-dialkyl-4,4'-diaminodiphenylmethanen. | |
GR75239B (da) | ||
ES2132308T3 (es) | 4-(2-cloro-3-ciano-fenil)-1,4-dihidro-2,6-dimetil-piridina-3,5-dicarboxilato de isopropilo y 2-metoxietilo. | |
ES2066897T3 (es) | 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida. | |
DK163245C (da) | Middel til behandling af neurologiske forstyrrelser eller lidelser | |
DK0412941T3 (da) | Phospholipider til behandling af dissemineret sklerose | |
FR2700695B1 (fr) | Composition thérapeutique nouvelle remédiant aux désordres survenant dans la sphère ORL. | |
ATE91886T1 (de) | Praeparat zur behandlung von erektionsstoerungen. | |
DE69032312T2 (de) | Anistreplase zur behandlung des hirnschlags | |
ES512654A0 (es) | "mejoras introducidas en el objeto de la patente principal n 497.716, por: perfeccionamientos introducidos en las correderas sencillas o de giro para lama verticales". |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |